Markets

Howard Blackburn knows exactly why the company to which he has devoted more than 30 years of his working life, is in his opinion a game changer for those looking to keep fit in the second half of their lives. "Because we are the only product, the only manufacturer, who has focused all of its [...]

Two university students have developed a mobile app that can detect within seconds if someone is suffering from a range of serious and potentially debilitating age-related eye conditions. The brainchild of Igor García Atutxa and Francisca Villanueva, the app uses artificial intelligence to analyse a selfie and issue a diagnosis, directing the taker toward the [...]

A simple blood test that can detect and screen with 96% accuracy whether a person has Alzheimer's disease up to a decade before symptoms appear, has been made available to the general public for the first time. The blood test developed by an international research team led by scientists from the Hong Kong University of [...]

A novel combination prostate cancer therapy has been approved by the US Food and Drug Administration. The new treatment combines two Pfizer-produced cancer drugs, Xtandi (also known as enzalutamide) and Talzenna (which also goes under the name talazoparib). While Xtandi is a medication typically used for prostate cancer, the addition of Talzenna - an oral [...]

With grocery prices sitting at a 45-year high thanks to the UK's rampant inflation, consumers could be forgiven for thinking they're about to suffer a stroke when they reach the supermarket checkout. But help could soon be at hand for shoppers whose blood pressure is being pushed to the limit - and it comes in [...]

Multinational pharmaceutical company AstraZeneca has teamed up with 'young' Chinese biotech Cholesgen to develop new drugs to target high cholesterol and related metabolic diseases. The three-year collaboration will see Shanghai-based Cholesgen receive an initial payment and a pre-defined license package for each qualified drug candidate nominated by UK-headquartered AstraZeneca to progress into clinical development. The [...]

Visually impaired iPhone users can now download two new free apps developed to give them more autonomy in their everyday lives. Created by a team based at the University of Michigan, VizLens is essentially a screen reader that employs a person's smartphone camera to allow them to understand and operate a variety of interfaces in [...]

Wrinkles are a natural part of ageing. But few of us welcome their appearance. Whilst we may be prepared to embrace the wisdom and experience that comes with age, the same can't be said of those telltale lines, creases, furrows and folds that so visibly announce to the world that our salad days are behind [...]

Breakthrough Alzheimer's drug Leqembi has received the unanimous support of a US Food and Drug Administration advisory panel - all but ensuring full approval for the first of its class treatment. The FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 6-0 that data showed Leqembi - also known as lecanemab - demonstrated [...]

An insertable Bluetooth-enabled cardiac monitor offering the world's longest battery life has been cleared for use in the US by the country's Food and Drug Administration. Global healthcare player Abbott's Assert-IQ will give physicians a new option for diagnostic evaluation and long-term surveillance of people experiencing irregular heartbeats. Known as arrhythmias, the heart can beat too [...]